More Boom or…Bust – What to expect from AI in biotech in 2025?

In some respects, 2024 has been a record year for AI in biotech,
with the $1 billion founding of the antibody-centered biotech
company Xaira and the awarding of the Nobel Prize in Chemistry to
DeepMind researchers Demis Hassabis, John Jumper, and David Baker.
However, despite years of investment and innovation, we still lack
an answer to the most pressing question: Will AI revolutionize drug
development, or are we in a bubble that is about to burst? In
episode 30 of the BioRevolution podcast, Andreas Horchler and
Louise von Stechow explore various use cases for AI in biotech—from
discovery to clinical development, from chemistry to biology, and
from data-centric to algorithm-centric AI strategies—trying to
assess where the biggest payoff will be. Disclaimer: Louise von
Stechow & Andreas Horchler and their guests express their
personal opinions, which are founded on research on the respective
topics, but do not claim to give medical, investment or even life
advice in the podcast. Learn more about the future of biotech in
our podcasts and keynotes. Contact us here: scientific
communication: https://science-tales.com/ Podcasts:
https://www.podcon.de/ Keynotes:
https://www.zukunftsinstitut.de/louise-von-stechow Image: Lucas
Favre, via Unsplash. Further reading: 1. OpenAI has created an AI
model for longevity science | MIT Technology Review 2.
https://www.techlifesci.com/p/a-google-maps-of-human-cells 3.
https://www.cas.org/resources/cas-insights/scientific-breakthroughs-2025-emerging-trends-watch#:~:text=Scientific%20breakthroughs%3A%202025%20emerging%20trends%20to%20watch%201,7%20Quantum%20computing%20getting%20practical%20...%20Weitere%20Elemente
4. Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI
And Trump 2.0 Are The Catalysts. | Investor's Business Daily 5.
Regeneron CSO George Yancopoulos on AI’s hype and potential 6.
Science in 2025: the events to watch for in the coming year 7.
Artificial intelligence and obesity management: An Obesity Medicine
Association (OMA) Clinical Practice Statement (CPS) 2023 - PMC 8.
Novo Nordisk expands AI partnership with Valo Health for
development of obesity drugs | Reuters 9. Profluent Unveils
OpenCRISPR-1, an AI-Designed Gene Editor 10. OpenAI has created an
AI model for longevity science | MIT Technology Review 11. Clinical
trial trends in 2025: Investments, wearables, and AI 12. What will
be the key trends in AI innovation in the Pharmaceutical Industry
in 2025? 13. Deep Genomics Introduces the Most Advanced AI
Foundation Model for RNA Disease Mechanisms and Candidate
Therapeutics | Deep Genomics 14. U of T researchers develop new
approach using quantum computers to accelerate drug discovery |
Temerty Faculty of Medicine 15. Quantum-computing-enhanced
algorithm unveils potential KRAS inhibitors | Nature Biotechnology
16. What are AI 'world models,' and why do they matter? |
TechCrunch 17. Empowering biomedical discovery with AI agents: Cell
18. https://youtu.be/CWEWBgVwFc8?si=dqLn2_qGflGf19xL 19. Virtual
lab powered by ‘AI scientists’ super-charges biomedical research
20. A New Kid On the Block: AI World Models In Biotech 21. 2025 AI
Trends: Life Sciences Leaders on Data, Digital and AI | ZS 22.
Scaling gen AI in the life sciences industry | McKinsey 23.
https://www.geeksforgeeks.org/what-is-quantum-ai/ 24. Key takeaways
from FDA’s draft guidance on use of AI in drug and biological life
cycle | DLA Piper 25. Navigating the EU AI Act: implications for
regulated digital medical products | npj Digital Medicine 26.
Isomorphic Labs CEO Demis Hassabis bets on biotech’s AI future 27.
De novo designed proteins neutralize lethal snake venom toxins |
Nature 28. A policy framework for leveraging generative AI to
address enduring challenges in clinical trials | npj Digital
Medicine 29. TrialGPT: NIH algorithm uses AI to match patients to
clinical trials | Association of Health Care Journalists 30. The
promise and perils of synthetic data | TechCrunch 31. Profluent |
Edit